Katan Ognjen, Michelena Hector I, Avierinos Jean-Francois, Mahoney Douglas W, DeSimone Daniel C, Baddour Larry M, Suri Rakesh M, Enriquez-Sarano Maurice
Department of Internal Medicine, Mayo Clinic, Rochester, MN.
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2016 Mar;91(3):336-42. doi: 10.1016/j.mayocp.2015.12.006. Epub 2016 Feb 5.
To determine the incidence and predictors of infective endocarditis (IE) in a population-based cohort of patients with mitral valve prolapse (MVP).
We identified all adult Olmsted County residents with MVP diagnosed by echocardiography from January 1989 to December 1998 and cross-matched them with the Rochester Epidemiology Project-identified Olmsted County cases of IE from January 1, 1986, through December 31, 2006. We retrospectively analyzed and de novo confirmed each IE case using the modified Duke criteria.
There were 896 Olmsted County residents with echocardiographically diagnosed MVP (mean age, 53±21 years; 565 women [63%]). The mean follow-up period was 11±5 years. The 15-year cohort risk of IE after MVP diagnosis was 1.1%±0.4% (incidence, 86.6 cases per 100,000 person-years; 95% CI, 43.3-173.2 cases per 100,000 person-years); thus, the age- and sex-adjusted relative risk of IE in patients with MVP was 8.1 (95% CI, 3.6-18.0) in comparison to the general population of Olmsted County (P<.001). There were no IE cases in patients without previously diagnosed mitral regurgitation (MR). Conversely, IE incidence was higher in patients with MVP with moderate, moderate-severe, or severe MR (289.5 cases per 100,000 person-years; 95% CI, 108.7-771.2 cases per 100,000 person-years; P=.02 compared with trivial, mild, or mild-moderate MR) and in patients with a flail mitral leaflet (715.5 cases per 100,000 person-years; 95% CI, 178.9-2861.0 cases per 100,000 person-years; P=.02 compared with no flail mitral leaflet).
The population-based incidence of IE in adults with MVP is higher than those previously reported in case-control, tertiary care center studies. Patients with MVP and moderate, moderate-severe, or severe MR or a flail mitral leaflet are at a notable risk of developing IE in comparison with those without MR.
确定二尖瓣脱垂(MVP)人群队列中感染性心内膜炎(IE)的发病率及预测因素。
我们识别出1989年1月至1998年12月期间经超声心动图诊断为MVP的所有奥姆斯特德县成年居民,并将他们与罗切斯特流行病学项目识别出的1986年1月1日至2006年12月31日期间奥姆斯特德县的IE病例进行交叉匹配。我们使用改良的杜克标准对每个IE病例进行回顾性分析并重新确诊。
有896名奥姆斯特德县居民经超声心动图诊断为MVP(平均年龄53±21岁;565名女性[63%])。平均随访期为11±5年。MVP诊断后15年队列中IE的风险为1.1%±0.4%(发病率为每10万人年86.6例;95%可信区间为每10万人年43.3 - 173.2例);因此,与奥姆斯特德县普通人群相比,MVP患者经年龄和性别调整后的IE相对风险为8.1(95%可信区间为3.6 - 18.0)(P<0.001)。先前未诊断出二尖瓣反流(MR)的患者中无IE病例。相反,中度、中重度或重度MR的MVP患者(每10万人年289.5例;95%可信区间为每10万人年108.7 - 771.2例;与轻度、轻度 - 中度MR相比,P = 0.02)以及二尖瓣叶连枷样改变的患者(每10万人年715.5例;95%可信区间为每10万人年178.9 - 2861.0例;与无二尖瓣叶连枷样改变相比,P = 0.02)的IE发病率更高。
基于人群的成年MVP患者中IE的发病率高于先前病例对照研究和三级医疗中心研究报道的发病率。与无MR的患者相比,有中度、中重度或重度MR或二尖瓣叶连枷样改变的MVP患者发生IE的风险显著增加。